Takip et
Prof Dr Yusuf Yılmaz
Prof Dr Yusuf Yılmaz
Recep Tayyip Erdogan University
marmara.edu.tr üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...
Journal of hepatology 73 (1), 202-209, 2020
31472020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Gastroenterology 158 (7), 1999-2014.e1., 2020
25752020
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ...
Hepatology 69 (6), 2672-2682, 2019
16342019
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Hepatology 78 (6), 1966-1986, 2023
14462023
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ...
PLoS medicine 11 (7), e1001680, 2014
7272014
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ...
Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019
6812019
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
M Eslam, SK Sarin, VWS Wong, JG Fan, T Kawaguchi, SH Ahn, ...
Hepatology international 14, 889-919, 2020
5932020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation …
PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ...
The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020
5532020
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
4582022
Apoptosis: why and how does it occur in biology?
E Ulukaya, C Acilan, Y Yilmaz
Cell biochemistry and function 29 (6), 468-480, 2011
3092011
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ...
Gut 71 (5), 1006-1019, 2022
2992022
is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?
Y Yilmaz
Alimentary pharmacology & therapeutics 36 (9), 815-823, 2012
2942012
NASH in lean individuals
R Younes, E Bugianesi
Seminars in liver disease 39 (01), 086-095, 2019
2382019
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
Y Yilmaz, F Eren, O Yonal, R Kurt, B Aktas, CA Celikel, O Ozdogan, ...
European journal of clinical investigation 40 (10), 887-892, 2010
2302010
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, S Aker, ...
World journal of gastroenterology: WJG 13 (6), 837, 2007
2242007
Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
Y Yilmaz, O Yonal, R Kurt, YO Alahdab, F Eren, O Ozdogan, CA Celikel, ...
Scandinavian journal of gastroenterology 46 (1), 91-97, 2011
1762011
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1742022
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ...
Journal of hepatology 76 (4), 771-780, 2022
1722022
Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis
Y Yilmaz, O Yonal, O Deyneli, CA Celikel, C Kalayci, DG Duman
Acta gastro-enterologica Belgica 75, 240-4, 2012
1532012
Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease
ZM Younossi, M Stepanova, J Ong, Y Yilmaz, A Duseja, Y Eguchi, ...
Clinical Gastroenterology and Hepatology 17 (8), 1625-1633. e1, 2019
1382019
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20